FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry, in particular to an antiviral agent. Antiviral agent, based on extract of basidiomycete Coprinus comatus (O.F. Müll.) Pers., which contains a dry extract of said fungus, prepared by drying ethanol extract of biologically active substances, ground and homogenised feed components at a certain content in dry extract of aqueous solution in which concentration of at least 1.0 mg/ml has antiviral activity against RNA genome of influenza A virus subtypes H3N2 and H5N1.
EFFECT: described agent is effective against RNA genome of influenza A virus subtypes H3N2 and H5N1.
1 cl, 6 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIVIRAL AGENT BASED ON DRY EXTRACT OF FRUIT BODY OF XYLOTROPHIC BASIDIOMYCETES Bjerkandera adusta | 2015 |
|
RU2580296C1 |
| ANTIVIRAL AGENT BASED ON TOTAL AMOUNT OF FLAVONOIDS FROM Alchemilla vulgaris L | 2015 |
|
RU2580304C1 |
| ANTIVIRAL AGENTS BASED ON CULTURE EXTRACT OF "HAIRY ROOTS" OF NITRARIA SCHOBERI L. | 2016 |
|
RU2615376C1 |
| ANTIVIRAL AGENT BASED ON DRY EXTRACT OF LICHEN Cetraria islandica | 2015 |
|
RU2580305C1 |
| ANTIVIRAL AGENT BASED ON SERRATIA-FAMILY BACTERIA NUCLEASE | 2014 |
|
RU2580242C2 |
| STRAIN OF SERRATIA SPECIES BACTERIA HAVING ANTIVIRAL ACTIVITY | 2017 |
|
RU2650762C1 |
| STRAIN OF BACTERIA Serratia plymuthica HAVING ANTIVIRAL ACTIVITY AGAINST INFLUENZA VIRUS OF TYPE A (VERSIONS) | 2013 |
|
RU2551316C1 |
| STRAIN OF BACTERIA Serratia species WHICH IS PRODUCER OF EXTRACELLULAR RIBONUCLEASE AND DEOXYRIBONUCLEASE HAVING ANTIVIRAL ACTIVITY | 2013 |
|
RU2528064C1 |
| INHIBITOR OF INFLUENZA A VIRUS REPRODUCTION BASE ON EXTRACT OF BASIDIAL FUNGUS Phallus impudicus | 2011 |
|
RU2475529C2 |
| WATER-SOLUBLE PIGMENT MELANIN FROM THE BASIDIOMYCETE INONOTUS OBLIQUUS WITH ANTIVIRAL ACTIVITY | 2022 |
|
RU2800446C1 |
